Unilever PLC

Regulatory Filings • Jan 8, 2026

National Storage Mechanism | Additional information

RNS Number : 1825O

Unilever PLC

08 January 2026

08 January 2026

Unilever PLC

Voting Rights and Capital Update

Correction made to Unilever PLC's RNS announcement related to total voting rights released on 2 January 2026 at 17:21 (RNS Number: 5408N): The original announcement included an erroneous reference to 319,412 ordinary shares (including ordinary shares represented by Unilever PLC ADSs) held by or on behalf of companies in the Unilever group resulting in 2,180,685,835 ordinary shares with voting rights. As of 31 December 2025, 314,912 ordinary shares (including ordinary shares represented by Unilever PLC ADSs) were held by or on behalf of companies in the Unilever group resulting in 2,180,690,335 ordinary shares with voting rights.

The amended announcement is set out in full below:

The following notification is made in accordance with the UK Financial Conduct Authority's Disclosure Guidance and Transparency Rule 5.6.1.

Unilever PLC's issued share capital as at 31 December 2025 consisted of 2,181,005,247 ordinary shares of 3 1/2p each. Of those ordinary shares, no shares were held as treasury shares and 314,912 ordinary shares (including ordinary shares represented by Unilever PLC ADSs) were held by or on behalf of companies in the Unilever group (the "Unilever Group Shares"). The voting rights attaching to the Unilever Group Shares are not exercisable. Accordingly, as at 31 December 2025, there were 2,180,690,335 shares with voting rights.

The figure of 2,180,690,335 may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, Unilever PLC under the UK Financial Conduct Authority's Disclosure Guidance and Transparency Rules.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

TVRUWARRNNUARAR